GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's DiseaseYazhou Li, Nigel H. Greig, Kara B. Duffy et al.|Journal of Alzheimer s Disease|2010Cited by 325
GLP1 receptor agonism ameliorates Parkinson’s disease through modulation of neuronal insulin signalling and glial suppressionDilan Athauda, Sonia Gandhi, Patricia Lopez-Garcia et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 7